chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a professional nurse referring to unspecified number of patients of unknown age and gender. Patient's pertinent medical history, drug reaction/allergies or concomitant information were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of PNEUMOVAX23 lot # L003227 - Expiration date: 13-OCT-2016 (strength, dose and route were not provided). No symptoms were reported. The reporter stated that duration of the improperly storage was about a time frame of 3 hours, and reported temperature was 58 degrees F. The vaccines did not undergo a previous temperature excursion. There was no data logger issue reported. This is one of several reports received from the same reporter. Additional information has been requested.
she experienced arm soreness for a day after receiving the Pfizer covid vaccine; This is a spontaneous report from a Non-contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. Medical history included asthma, food, cardiac failure, psoriasis and she's taking several meds to manage these conditions. The patient's concomitant medications were not reported. This morning she experienced arm soreness for a day after receiving the Pfizer covid vaccine. Outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot been obtain. No further information is expected.
Fever, chills, nausea, headache, injection site pain on the first day after shot on March 26th. On day two after injection all the other symptoms subsided, but headache continued. On April 1st the fever, chills,and nausea returned and temperature had reached 100.8 degrees and headache intensified. On April 2nd I woke up feeling better but still had the headache, as the day progressed the chills and fever returned with temperatures up to 100°. On April 3rd I woke up with no temperature but the headache continued. On April 4th The headache finally went away. My treatment was plenty of water aspirin, ibuprofen, acetaminophen and bed rest.
Immunocompromised patient received booster dosage instead of the dosage of 3rd dose,Received the booster, but only 0.25 ml instead of full dose; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dosage instead of the dosage of 3rd dose,Received the booster, but only 0.25 ml instead of full dose) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dosage instead of the dosage of 3rd dose,Received the booster, but only 0.25 ml instead of full dose). On 23-Oct-2021, INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dosage instead of the dosage of 3rd dose,Received the booster, but only 0.25 ml instead of full dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided. Treatment drugs were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Oct-2021: Follow up received and patient demographics were added, dose 1 and 2 details were added and new event added.
(R) deltoid small lump 2 cm in diameter, mild tenderness. Warm compresses to affected area,
flu; Initial information received on 09-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer or non-healthcare professional  This case involves patient (unknown demographics) who experienced flu (influenza), when received INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received any corrective treatment.  The event outcome was unknown for influenza.  There will be no information available on the batch number for this case.
The day after Pneumonia injection my upper right arm from elbow to shoulder was red, hot to touch, swollen and very painful. It looked like cellulitis. The inner arm was worse that the outer area where the actual shot was given it lasted 4 days.
Right sided neck stiffness with head and eye twitching developed on 2/21/22.  Also has tenderness over sternocleidomastoid muscle.  Was seen at Emergency Dept. on 2/22/22.  Diagnosed with Acute torticollis.  Pain and twitching did not stop.  Followed up with Dr. on 3/4/22 for same continued symptoms.  Referral to neurology.  Lab work normal.  Mother is treating with ibuprofen and heating pad.  Spoke with mother today and there has been no change.
Information has been received on 10/14/2002 from a mother concerning her son with no past medical history and no known allergies who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  There was no concomitant medication.  The mother reported that her son had a "rash on arm where he was vaccinated."  The patient sought unspecified medical attention.  Additional information has been requested.
Patient received expired dose. No adverse effects at this time. Vial left on counter from previous day labeled with expiration 4-24. LPN did not check sticker's expiration date and did not ask for verification of vaccination. Error was found in afternoon. LPN was re-educated on correct procedure. LPN will be notifying patient of error.
COAGULOPATHY, UNSPECIFIED TYPE 3/7/2023 SOLITARY PULMONARY NODULE COAGULOPATHY, UNSPECIFIED TYPE 3/7/2023 ATHEROSCLEROSIS OF AORTA
About 10 min after giving shots pt returned to pharmacy stating tongue felt like it was getting big. Immediately gave her BENADRYL PO 25mg. 10 min after that her lips were tingling so gave her 1 dose EPIPEN to Rt thigh & called 911. Due to heart arrhythmic history paramedic took her to hospital.
Higher heart rate; Headache for two days; Inject an arm really hurt and joint pains within that arm; Inject an arm really hurt and joint pains within that arm; Light rash round the 24 hours mark after shot; This is a spontaneous report from a contactable consumer (reported for herself). A 41-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 06Mar2021 at 04:30 (at the age of 41-years-old) as dose 1, single for COVID-19 immunisation at Hospital. Medical history included Asthma, High blood pressure, Allergy, Penicillin family and Seasonal allergies. Concomitant medication(s) included naproxen (NAPROXEN), loratadine (CLARITIN [LORATADINE]), montelukast (MONTELUKAST), losartan (LOSARTAN) and fluticasone (FLUTICASONE), all the drugs taken for an unspecified indication, start and stop date were not reported. It was unknown if patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021 at 17:00, the patient experienced higher heart rate, headache for two days, inject an arm really hurt and joint pains within that arm and light rash round the 24 hours mark after shot. No treatment was given for the events. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Narrative: 07/27/2020 COVID swab, result: not detected 11/19/2020 COVID swab, result: not detected COVID infection following COVID vaccine series 05/25 COVID swab, result: not detected 06/15 Janssen, #1 08/07 pt cc: cough, diarrhea, fatigue, loss of taste or smell, headache, rhinorrhea, myalgias, dyspnea exposure: spouse 08/09 COVID swab, result: detected 08/09 SARS-COV-2 LINEAGE AY.4 08/09 SARS-COV-2 CLADE 21A DELTA
This spontaneous report as received from a approximately 60 year old male physician referring to himself. The patients medical history included angioedema and shingles. Current conditions included multiple sclerosis and cardiovascular disease. No drug reactions or allergies were reported. On 22-JUN-2011, the patient was vaccinated with ZOSTAVAX dose, route not reported. No concomitant medication reported. On an unknown date in January 2014 (also reported as 6 weeks ago), the patient experienced shingles. The reporter also stated that he had developed shingles in his 30s and compared to his previous case of shingles this case of shingles was very tolerable. Laboratory diagnostics studies were not performed. The physician self prescribed himself acyclovir and LYRICA for treatment. The physician reported that for the last week he has been ok. Causality between ZOSTAVAX and the event shingles was not reported. Additional information has been requested.
Allergic reaction / had an allergic reaction to the first dose.; The other hospitals in the area don't have Moderna; Passed out; Throat started to tighten up; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out), ALLERGY TO VACCINE (Allergic reaction / had an allergic reaction to the first dose), and THROAT TIGHTNESS (Throat started to tighten up) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criteria medically significant and life threatening) and THROAT TIGHTNESS (Throat started to tighten up) (seriousness criterion life threatening). On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic reaction / had an allergic reaction to the first dose), (seriousness criterion life threatening) and PRODUCT DOSE OMISSION ISSUE (The other hospitals in the area don't have Moderna). The patient was treated with EPINEPHRINE (EPIPEN) for Allergy to vaccine, Throat tightness and Asthma, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Asthma, Allergy to vaccine and Throat tightness, at an unspecified dose and frequency. On 15-Jan-2021, LOSS OF CONSCIOUSNESS (Passed out) and THROAT TIGHTNESS (Throat started to tighten up) had resolved. At the time of the report, ALLERGY TO VACCINE (Allergic reaction / had an allergic reaction to the first dose), and PRODUCT DOSE OMISSION ISSUE (The other hospitals in the area don't have Moderna) outcome was unknown.            Concomitant medication use information was not provided by reporter. The patient had some asthmatic symptoms at times and with the delta variant on the rise, concern regarding getting second dose.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Additional information received on 9-AUG-2021 that contains significant information that includes case seriousness as Life threatning , added events( Throat tightness, Asthamatic  ), updated Benadryl drug and Zyrtec as treatment. updated patient demographics. Treatment medication updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Swollen right testicle; This spontaneous case was reported by a consumer and describes the occurrence of TESTICULAR SWELLING (Swollen right testicle) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included BUPRENORPHINE HYDROCHLORIDE (BELBUCA), METFORMIN, LISINOPRIL and ATORVASTATIN for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TESTICULAR SWELLING (Swollen right testicle). At the time of the report, TESTICULAR SWELLING (Swollen right testicle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
abscess devel over inject site; post administration of DT pt had c/o intermittent redness & swelling which has resolved;
Pt vacc. /w Measles virus 26May90. A day & 1/2 /p vacc. pt had grand mal sizure. Pt in ER. 19Jul90 MRI scan and EEG demonstrated minimal abnormality. Additional info. requested.
had a red spot on her collar bone that is migrating towards her chest; rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her arm) and RASH MACULAR (had a red spot on her collar bone that is migrating towards her chest) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included USTEKINUMAB (STELARA) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (rash on her arm) and RASH MACULAR (had a red spot on her collar bone that is migrating towards her chest). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (rash on her arm) and RASH MACULAR (had a red spot on her collar bone that is migrating towards her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
A week after his vaccination he started to get a bad rash on the site of his vaccination site. Spread to about 3 inches in diameter. On the 3rd day it started to look like a bullseye so we decided to take him in to see the physician at the urgent care. He had no other symptoms other than the rash. We were recommended Amoxicillin because they believed that it was a tick bite. Rash has completely disappeared by the next day after visiting the doctor.
Information was received from a lawyer regarding a case in litigation involving a female patient, age and medical history not provided. On or about 07-JAN-2014 the patient was inoculated with ZOSTAVAX vaccine at a pharmacy for routine adult health maintenance and the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2016 the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX r despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
Diarrhea, for 19 days after first vaccine; Tired, after first vaccine; lost 5 pounds; This is a spontaneous report received from a contactable consumer (patient himself). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Batch/Lot number: Unknown, Expiration Date: Unknown), via an unspecified route of administration on 26Apr2021 at 1st dose, single for COVID-19 immunization. The patient's medical history included asthma, chronic bronchitis and congestive heart failure. The patient's concomitant medications were not reported. The patient underwent lab tests and procedures which included Feces test: no indication that he has any systemic problems, blood test: no indication that he has any systemic problems, Urine sample: no indication that he has any systemic problems on an unspecified date. The patient experienced diarrhea, for 19 days after first vaccine, tired, after first vaccine, lost 5 pounds all are on an unspecified date in 2021. The events assessed as non-serious. The outcome of the events was unknown.  Information about batch/lot number is requested.
pt recvd vax;diffuse flushing on face,upper body & arms;extensive erythema & pruritus over body w/ substernal tightness & diff breathing;tx epi & dph;
Completed Moderna series on 02/12/2021. Diagnosed with COVID-19 on 04/06/2021 and expired from COVID-19 pneumonia on 04/06/2021
This spontaneous report was received from a registered nurse referring to a patient of unknown age. On 05-JAN-2016 the patient was vaccinated with a dose of improperly stored oral, ROTATEQ (Lot # L022447, exp date: 26-JUN-2017). The product was stored in temperature of 50.2 F degrees for 1 hour and 10 minutes. The temperature excursion was recorded by a data logger. There was no previous temperature excursion. No adverse effects reported. This is one of several reports received from same source. Additional information has been requested.
started middle afternoon leg swelled up twice nl size, very red, hot & hard;use cold packs temp also up to 104-105-48hrs;no relief w/APAP;very irritable, up most of noc;would not cry when hold;
Atrial Fibrillation that developed 18 days after the first vaccine dose. Felt change in HR, some chest pain.
two days after the shot a large read swollen and itching rash developed under the shot site on the arm it is still present, 2 days after it first started
pt recvd 3 doses of Engerix-B was determined to have a non-response;
Severe rash, fever, chills, headache lasting about 5 days (not yet over it) Treated with prednisone
This subject is a 72 year old female who died in her home while enrolled in a study. The subject received two doses of the study vaccine. The last dose prior to the death was given on 10/6/03. The subject's daughter reported that her mom was found dead in her home on 3/17/04, 163 post immunization. Suspected cause of death is a heart attack. No autopsy performed. Subject was not brought to the hospital. The death was reported by the investigator as unrelated to the study vaccine. Nurse follow up on 05/17/04 states: COPD, Hypertensive cardiovascular disease (Lung dis, Cardiovasc dis). The death was reported by the investigator as unrelated to the stud vaccine. Additional information received 7 April 2004. Concomitmant therapies and relevant medical history. Cross reference with 2003-00300 (SAE #2003-0-1056)- Same patient.
Pt had vaccine 6/11/12. Pt noticed irritation at site 6/12/12. On 6/13/12 she noticed it was red, swollen, mildly itchy & irritated.
Patient received the vaccine because mom knowingly indicated, confirmed, and initialed a false date of birth so her son can get the vaccine before a trip. Real date of birth was found out after administration form the insurance company.
Information has been received from a medical assistant concerning a male patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On 20-JAN-2017, the patient was vaccinated with: VARIVAX (lot #: M030138 with expiration date: 15-JUN-2018) (dose, dosage schedule and anatomical location were not reported) subcutaneously, for prophylaxis; and with M-M-R II (lot #: M029229 with expiration date: 08-JUN-2018) (dose, dosage schedule and anatomical location were not reported) subcutaneously, for prophylaxis. These two vaccines had been drawn into plastic syringes and had been stored at refrigerated temperatures (36°F-46°F) for eight days. No adverse effects were reported.  Additional information has been requested.
Child came in for her second dose of pfizer in the school setting and the staff did not catch that she had just turned twelve and therefore should not have received the pediatric dose she was given.
red area on my arm; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (extreme nausea) and VACCINATION SITE ERYTHEMA (red area on my arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Headache and Weakness.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced NAUSEA (extreme nausea). On 19-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area on my arm). At the time of the report, NAUSEA (extreme nausea) and VACCINATION SITE ERYTHEMA (red area on my arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included ondansetron.
Pt felt dizzy, dry throat following flu vaccine. Continued to feel dizzy, weak, lightheaded, and dyspneic on exertion at work.  Sought medical care 3 weeks later and was started on Avlelox on 10/27/11 and saw her PCM on 11/7/11 and was also started on Advair. Told at that time she had a "lung" infection and elevated BP.  Continued to work until 11/18/11 until she sought emergency care for increasing SOB.  Was hospitalized x 5 days at that time.  Is continuing care and treatment with a cardiologist.  Returned to work full time on 3 January with a limited duty profile to not walk more than 50 feet at a time.
Tingling and itching in both hands, same allergic reaction I have with Erythromycin and Sulfa
Burning and abdominal pain sensation. Strong and fast heartbeat, and sometimes very slow heartbeat.
Headache Muscle Soreness Chills  Fever ( 100 Degrees Fahrenheit) Treatment: 400 mg of ibuprofen
Pt became ill the day after receiving the shot. She had high fever 101-102 F with throbbing headache, chills, aches and violent vomiting.  Of note, Pt was positive for Covid 19 and sick for about 13 days with high fever in April of 2020 (almost a year before the shot).  Also, this was her second dose of the Covid 19 vaccine and she had the same reaction to the first shot.